scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)

CUSIP: 810648105

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
53,364,241
Total 13F shares
39,775,602
Share change
+2,402,710
Total reported value
$140,807,820
Put/Call ratio
15%
Price per share
$3.54
Number of holders
84
Value change
+$5,279,129
Number of buys
46
Number of sells
40

Quarterly Holders Quick Answers

What is CUSIP 810648105?
CUSIP 810648105 identifies SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ORBIMED ADVISORS LLC
13F 3/4/5
Company · 10%+ Owner
11%
6,059,528
$27,631,448 30 Sep 2024
Rubric Capital Management LP
13F
Company
8.9%
4,775,000
$21,774,000 30 Sep 2024
13F
AIGH Capital Management LLC
13F
Company
7.7%
4,124,367
$18,807,113 30 Sep 2024
13F
5AM Partners IV, LLC
3/4/5
10%+ Owner
class O/S missing
2,734,852
$17,475,704 06 Oct 2022
KING LUTHER CAPITAL MANAGEMENT CORP
13F
Company
4.2%
2,225,790
$10,149,602 30 Sep 2024
13F
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
3.8%
2,049,009
$9,343,481 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
3.5%
1,853,749
$8,453,095 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
3.2%
1,708,946
$7,792,794 30 Sep 2024
13F
J. Goldman & Co LP
13F
Company
2.6%
1,379,993
$6,292,768 30 Sep 2024
13F
5AM Venture Management, LLC
13F
Company
2.2%
1,200,647
$5,474,951 30 Sep 2024
13F
THRIVENT FINANCIAL FOR LUTHERANS
13F
Company
2%
1,048,938
$4,783,000 30 Sep 2024
13F
KINGDON CAPITAL MANAGEMENT, L.L.C.
13F
Company
1.5%
800,000
$3,648,000 30 Sep 2024
13F
Stonepine Capital Management, LLC
13F
Company
1.5%
778,874
$3,551,665 30 Sep 2024
13F
AWM Investment Company, Inc.
13F
Company
1.4%
764,857
$3,487,748 30 Sep 2024
13F
Nantahala Capital Management, LLC
13F
Company
1.4%
750,000
$3,420,000 30 Sep 2024
13F
STATE STREET CORP
13F
Company
1.3%
682,135
$3,110,536 30 Sep 2024
13F
Tejara Capital Ltd
13F
Company
1.2%
650,265
$2,965,208 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.2%
643,342
$2,933,904 30 Sep 2024
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
1.2%
621,665
$2,834,792 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.99%
525,964
$2,398,396 30 Sep 2024
13F
Velan Capital Investment Management LP
13F
Company
0.97%
517,668
$2,360,566 30 Sep 2024
13F
Woodline Partners LP
13F
Company
0.94%
501,608
$2,287,332 30 Sep 2024
13F
Walleye Capital LLC
13F
Company
0.89%
475,555
$2,168,531 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.62%
332,654
$1,516,903 30 Sep 2024
13F
Monashee Investment Management LLC
13F
Company
0.6%
319,795
$1,458,265 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.48%
255,134
$1,163,412 30 Sep 2024
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.47%
249,260
$1,136,626 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.34%
179,653
$819,218 30 Sep 2024
13F
APIS CAPITAL ADVISORS, LLC
13F
Company
0.3%
160,000
$729,600 30 Sep 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.26%
141,136
$643,580 30 Sep 2024
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.26%
139,900
$637,944 30 Sep 2024
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.15%
80,706
$368,019 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.14%
75,890
$346,058 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.14%
74,769
$340,946 30 Sep 2024
13F
Connective Capital Management, LLC
13F
Company
0.15%
79,593
$330,311 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.13%
69,123
$315,203 30 Sep 2024
13F
Balanced Rock Investment Advisors LLC
13F
Company
0.12%
64,750
$295,260 30 Sep 2024
13F
GROUP ONE TRADING LLC
13F
Company
0.12%
63,708
$290,508 30 Sep 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.11%
58,656
$267,471 30 Sep 2024
13F
BARCLAYS PLC
13F
Company
0.08%
40,644
$185,336 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.08%
40,390
$184,179 30 Sep 2024
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.07%
38,771
$177,000 30 Sep 2024
13F
Thomasville National Bank
13F
Company
0.07%
37,500
$171,000 30 Sep 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.07%
35,442
$161,604 30 Sep 2024
13F
SCOGGIN MANAGEMENT LP
13F
Company
0.06%
34,084
$155,423 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.06%
33,152
$151,275 30 Sep 2024
13F
CITIGROUP INC
13F
Company
0.05%
28,417
$129,582 30 Sep 2024
13F
XTX Topco Ltd
13F
Company
0.05%
27,169
$123,891 30 Sep 2024
13F
MARSHALL WACE, LLP
13F
Company
0.04%
23,646
$107,825 30 Sep 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.04%
23,485
$107,092 30 Sep 2024
13F

Institutional Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) as of Q4 2024

As of 31 Dec 2024, scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) was held by 84 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,775,602 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Rubric Capital Management LP, AIGH Capital Management LLC, KING LUTHER CAPITAL MANAGEMENT CORP, BlackRock, Inc., VANGUARD GROUP INC, MORGAN STANLEY, SUVRETTA CAPITAL MANAGEMENT, LLC, J. Goldman & Co LP, and 5AM Venture Management, LLC. This page lists 84 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
93
Q4 2024 holders
84
Holder diff
-9
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .